DENOZEP-50 ER - Desvenlafaxine 50mg ER | Intralife Pharmaceuticals
PSYCHOLIFE
Top

DENOZEP-50 ER

MRP: 1,200

Packaging: 10x10

Pack Type: tablet

Composition:

Desvenlafaxine 50mg ER

Indication:

Major Depressive Disorders, Vasomotor Symptoms

Description:

Desvenlafaxine 50 mg ER is an extended-release serotonin-norepinephrine reuptake inhibitor (SNRI) prescribed to treat major depressive disorder (MDD). It works by increasing serotonin and norepinephrine levels in the brain, which helps elevate mood, relieve anxiety, and improve overall mental well-being.

The extended-release formulation allows for once-daily dosing and provides steady medication levels, enhancing compliance and minimizing side effects. It is suitable for adults and helps improve symptoms of depression, including low energy, sadness, and difficulty concentrating.

Tags:

Antidepressant SNRI Depression Mental Health Prescription Medication
  • Effective treatment for major depressive disorder
  • Reduces anxiety and improves overall mood
  • Extended-release for convenient once-daily dosing
  • Helps with energy, focus, and sleep regulation
  • Generally well tolerated with manageable side effects

Usage Information

Dosage

Typical dose: 50 mg once daily, preferably in the morning Take with or without food Adjustments only under doctor supervision Do not abruptly discontinue medication

Side Effects

Common: Nausea Dizziness Dry mouth Sweating Insomnia or drowsiness Serious (seek medical attention): Suicidal thoughts or behavior Allergic reactions (rash, swelling) High blood pressure Serotonin syndrome symptoms (confusion, rapid heartbeat)

Contraindications

Hypersensitivity to Desvenlafaxine or ingredients Concurrent use with MAO inhibitors Pregnancy and breastfeeding caution advised Use with caution in patients with hypertension or bipolar disorder

Availability

Desvenlafaxine 50mg ER, extended-release antidepressant, SNRI medication, depression treatment, anxiety relief, mood stabilizer

Desvenlafaxine 50mg ER for Depression & Anxiety Treatment | Intralife Pharmaceuticals | Intralife